Valiant Navion™ VNMF2828C174TU (UDI 00763000100582)Recalls & reported problems
Medtronic, Inc. · STENT GRAFT VNMF2828C174TU VAL NAV FF · Class 3 · Implant
All models of Valiant Navion (137)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 2
- Deaths reported
- 1
- Injuries reported
- 1
- Recalls naming it
- 1
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00763000100582), received between Nov 22, 2022 and Jan 23, 2023 — classified as 1 death, 1 injury.
The most frequently reported specific device problem is “Leak/Splash” (1 report).
1 FDA recall record name this device's identifier, 1 still open.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Recalls naming this device
- Feb 12, 2021Class IOpen, Classified
Due to the presence of type IIIb endoleaks, stent fractures, and stent ring enlargement.
Z-1201-2021 · Root cause: Under Investigation by firm · Recall details · FDA record ↗
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
- Leak/Splash1
Patient problems
- Cognitive Changes1
- Insufficient Information1
- Sepsis1
- Unspecified Infection1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
DeathJan 23, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A VALIANT NAVION STENT GRAFT WAS IMPLANTED DURING THE ENDOVASCULAR TREATMENT OF A SACCULAR THORACIC AORTIC ANEURYSM. IT WAS REPORTED APPROXIMATELY 8 MONTHS POST THE INDEX PROCEDURE, THE PATIENT PRESENTED EMERGENTLY WITH AMS. ON EVALUATION SEPSIS WAS SUSPECTED DUE TO A GRAFT INFECTION. THE PATIENT WAS NOTED TO BE A VERY POOR SURGICAL CANDIDATE AND INSTEAD A COURSE OF ANTIBIOTICS WAS CONSIDERED HOWEVER THE PATIENT EXPIRED BEFORE PROGRESSION OF TREATMENT. PER THE PHYSICIAN THE CAUSE OF THE INFECTION AND DEATH ARE UNDETERMINED.
Patient problems: Cognitive Changes; Sepsis; Unspecified Infection
MAUDE report 16223487 ↗InjuryNov 22, 2022Leak/Splash; Leak/Splash
A VALIANT NAVION STENT GRAFT WAS IMPLANTED DURING THE ENDOVASCULAR PROCEDURE OF A THORACIC DISSECTION . IT WAS REPORTED THAT FOLLOW UP CT THE FOLLOWING MONTH IDENTIFIED A TYPE IA ENDOLEAK. THERE WAS NO STENT FRACTURE , STENT RING ENLARGEMENT OR STENT RING DISPLACEMENT OBSERVED. INTERVENTION WAS CARRIED OUT WHERE A SECOND VALIANT NAVION WAS IMPLANTED LESS THAN 2 WEEKS LATER TO TREAT THE ENDOLEAK. NO CAUSE PROVIDED. NO ADDITIONAL SEQUELAE WAS REPORTED AND THE PATIENT IS FINE.
Patient problems: Insufficient Information
MAUDE report 15841724 ↗
Other SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026 · each recall links to the FDA recall notice
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page